The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review

The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review

Abstract Background Although acute oxaliplatin-induced neuropathy (OXIPN) is frequently regarded to be transient, recent studies have reported prolongation of infusion times, dose reduction and treatment cessation following the first dose of oxaliplatin in quarter of patients. Acute OXIPN is also a...

Full description

Bibliographic Details
Main Authors: Endale Gebreegziabher Gebremedhn, Peter John Shortland, David Anthony Mahns
Format: Article
Language:English
Published: BioMed Central 2018-04-01
Series:BMC Cancer
Subjects:
Colorectal cancer
Oxaliplatin
Acute neuropathy
Chronic neuropathy
Online Access:http://link.springer.com/article/10.1186/s12885-018-4185-0

Internet

http://link.springer.com/article/10.1186/s12885-018-4185-0

Similar Items